C4276535||NANOBODY80
C0445022||LOOP
C2936235||PEPTIDOMIMETICS
C1623230||β2 ADRENERGIC RECEPTOR LIGANDS
C0682972||G protein-coupled receptors
C0682972||G protein-coupled receptors
C1659608||cellular responses
C0031327||mechanism of action
C0026377||conformation
C0682972||G protein-coupled receptors
C0230587||crystal structures
C4276535||Nanobody(Nb)
C0001643||β2-adrenergic receptor
C0001643||β2AR
C4276535||Nb80
C1167622||bind
C0178719||intracellular
C0086376||G protein
C1514535||binding site
C0001643||β2AR
C0597357||receptors
C0033625||active conformation
C4276535||Nb80
C0887928||complementarity-determining region 3
C0887928||complementarity-determining region 3
C1167622||binding interactions
C2936235||peptidomimetics
C0887928||complementarity-determining region 3
C0445022||loop
C0597358||binding to the receptor
C3269586||inhibiting
C1167622||interaction
C0001643||β2AR
C0178719||intracellular
C1749317||GPCR interacting
C0033684||proteins
C0086376||G proteins
C0010424||crystallographic data
C2936235||peptidomimetics
C4276535||Nb80
C0887928||complementarity-determining region 3
C0445022||loop
C1518960||-hairpin conformation
C1518960||conformationa
C1167622||binding
C1515653||in vitro assays
C2936235||peptidomimetics
C0026383||structurally
C0887928||complementarity-determining region 3
C0445022||loop
C4276535||Nanobody
C1527118||function
C2245433||inhibiting
C1819628||G protein coupling
C1157594||cAMP production